vimarsana.com

Latest Breaking News On - Cadila pharmaceuticals - Page 1 : vimarsana.com

Liposomal Doxorubicin Market to Grow at 6 7% CAGR, Reaching USD 2 3 Billion by 2033

Market OverviewThe Global Liposomal Doxorubicin Market is projected to witness significant growth over the next decade. Valued at USD 1.2 billion in 2023, the market is expected to reach approximately USD 2.3 billion by 2033, reflecting a compound annual growth rate (CAGR) of 6.7% from 2024 to 2033. This growth can.

Bulgarian in Cadila rape row seeks job back | India News

India News: AHMEDABAD: A Bulgarian woman employee who claimed unlawful sacking after she accused Cadila Pharmaceuticals CMD Rajiv Modi of rape last year will have.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.